表觀遺傳市場：趨勢、機會與競爭分析 [2023-2028]

表觀遺傳市場趨勢與預測

預計到2028年，全球表觀遺傳學市場將達到 36 億美元，2023年至2028年年複合成長率為 14.5%。該市場的主要促進因素是由於投資、資金籌措和核准的增加而加大表觀遺傳學研究和開發的配合措施，擴大表觀遺傳學在推動藥物研發發現和開發方面的應用，提高可負擔性和可及性，擴大基因組定序的可及性。全球表觀遺傳學市場的未來前景廣闊，為學術和研究機構、製藥公司、生物技術公司和委託研究組織 (CRO) 提供了商機。

表觀遺傳市場洞察

• Lucintel 預計，由於全球對易於使用、經濟高效和先進的表觀遺傳試劑盒和試劑的需求不斷成長，試劑盒和試劑在預測期內仍將是最大的細分市場。
• 在這個市場中，由於政府研究機構和大學實驗室廣泛採用表觀遺傳產品，學術和研究機構仍將是最大的最終用途區隔。
• 由於人們對先進醫療基礎設施的認知不斷增強、研發支出不斷增加以及該地區領先公司的存在，北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

• Q.1.細分市場中最有前途和高成長的機會為何？
• Q.2.哪個細分市場將以更快的速度成長？理由為何？
• Q.3.哪些地區未來會出現更快的成長？理由為何？
• Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和業務風險是什麼？
• Q.5.這個市場的商業風險和競爭威脅為何？
• Q.6.這個市場有哪些新趨勢？理由為何？
• Q.7.市場客戶需求有何改變？
• Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
• Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
• Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
• Q.11.過去年度發生了哪些並購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球表觀遺傳學市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

• 宏觀經濟趨勢（2017-2022）與預測（2023-2028）
• 全球表觀遺傳學市場趨勢（2017-2022）與預測（2023-2028）
• 依產品和服務分類的全球表觀遺傳學市場
  • 試劑盒和試劑
  • 酵素
  • 樂器及配件
  • 軟體
  • 服務
• 依技術分類的全球表觀遺傳學市場
  • DNA甲基化
  • 組蛋白甲基化
  • 其他
• 依最終用途行業分類的全球表觀遺傳學市場
  • 學術研究所
  • 製藥和生物技術公司
  • 合約研究組織（CRO）
  • 其他

第4章 2017-2028年分地區市場趨勢及預測分析

• 全球表觀遺傳學市場（依地區）
• 北美表觀遺傳學市場
• 歐洲表觀遺傳市場
• 亞太表觀遺傳學市場
• 其他區域表觀遺傳市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 依產品和服務分類的全球表觀遺傳學市場成長機會
  • 依科技分類的全球表觀遺傳學市場成長機會
  • 依最終用途產業的全球表觀遺傳學市場成長機會
  • 依地區分類的全球表觀遺傳學市場成長機會
• 全球表觀遺傳學市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球表觀遺傳市場的容量
  • 全球表觀遺傳學市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業概況

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Trends and Forecast

The future of the global epigenetic market looks promising with opportunities in the academic and research institutes, pharmaceutical companies and biotechnology companies, and contract research organizations (CROs). The global epigenetic market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.

A more than 150-page report is developed to help in your business decisions.

Epigenetic Market by Segment

The study includes trends and forecast for the global epigenetic market by product & service, technology, end use industry, and region as follows:

Epigenetic Market by Product & Service [Shipment Analysis by Value from 2017 to 2028]:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Epigenetic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Epigenetic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, epigenetic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the epigenetic companies profiled in this report include:

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Within this market, academics and research institutes will remain the largest end use segment due to the widespread adoption of epigenetic products across government research institutions and university laboratories.
• North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures, and the existence of major companies in this region.

Features of the Global Epigenetic Market

• Market Size Estimates: Epigenetic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Epigenetic market size by various segments, such as by product & service, technology, end use industry, and region in terms of value ($B).
• Regional Analysis: Epigenetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products & services, technologies, end use industries, and regions for the epigenetic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Epigenetic Market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the epigenetic market size?
• Answer: The global epigenetic market is expected to reach an estimated $3.6 billion by 2028.
• Q.2. What is the growth forecast for epigenetic market?
• Answer: The global epigenetic market is expected to grow with a CAGR of 14.5% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the epigenetic market?
• Answer: The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.
• Q4. What are the major segments for epigenetic market?
• Answer: The future of the global epigenetic market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
• Q5. Who are the key epigenetic companies?
• Answer: Some of the key epigenetic companies are as follows:
  • Abcam
  • Active Motiff
  • Hologic
  • F. Hoffmann-La Roche
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Novartis
  • Element Biosciences
  • Dovetail Genomics
• Q6. Which epigenetic market segment will be the largest in future?
• Answer: Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Q7. In epigenetic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures and the existence of major companies in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global epigenetic market by product & service (kits & reagents, enzymes, instruments & accessories, software, and services), technology (DNA methylation, histone methylation, and others), end use industry (academic and research institutes, pharmaceutical companies and biotechnology companies, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Epigenetic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Epigenetic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Epigenetic Market by Product & Service
  • 3.3.1: Kits & Reagents
  • 3.3.2: Enzymes
  • 3.3.3: Instruments & Accessories
  • 3.3.4: Software
  • 3.3.5: Services
• 3.4: Global Epigenetic Market by Technology
  • 3.4.1: DNA Methylation
  • 3.4.2: Histone Methylation
  • 3.4.3: Others
• 3.5: Global Epigenetic Market by End Use Industry
  • 3.5.1: Academic and Research Institutes
  • 3.5.2: Pharmaceutical Companies and Biotechnology Companies
  • 3.5.3: Contract Research Organizations (CROs)
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Epigenetic Market by Region
• 4.2: North American Epigenetic Market
  • 4.2.1: North American Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.2.2: North American Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.3: European Epigenetic Market
  • 4.3.1: European Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.3.2: European Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.4: APAC Epigenetic Market
  • 4.4.1: APAC Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.4.2: APAC Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.5: ROW Epigenetic Market
  • 4.5.1: ROW Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.5.2: ROW Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Epigenetic Market by Product & Service
  • 6.1.2: Growth Opportunities for the Global Epigenetic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Epigenetic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Epigenetic Market by Region
• 6.2: Emerging Trends in the Global Epigenetic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Epigenetic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abcam
• 7.2: Active Motiff
• 7.3: Hologic
• 7.4: F. Hoffmann-La Roche
• 7.5: Illumina
• 7.6: Qiagen
• 7.7: Thermo Fisher Scientific
• 7.8: Novartis
• 7.9: Element Biosciences
• 7.10: Dovetail Genomics